Literature DB >> 26287484

Correction: Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.

Sanne Christine van Kampen, Aigul Tursynbayeva, Aliya Koptleuova, Zauresh Murzakhmetova, Lyazzat Bigalieva, Moldir Aubakirova, Svetlana Pak, Susan van den Hof.   

Abstract

Entities:  

Year:  2015        PMID： 26287484      PMCID： PMC4545753          DOI： 10.1371/journal.pone.0136368

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The fourth author's name is spelled incorrectly. The correct name is: Zauresh Murzakhmetova. The correct citation is: van Kampen SC, Tursynbayeva A, Koptleuova A, Murzakhmetova Z, Bigalieva L, Aubakirova M, et al. (2015) Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study. PLoS ONE 10(7): e0132514. doi:10.1371/journal.pone.0132514.
  1 in total

1.  Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.

Authors:  Sanne Christine van Kampen; Aigul Tursynbayeva; Aliya Koptleuova; Zauresh Murzakhmetova; Zauresh Murzabekova; Lyazzat Bigalieva; Moldir Aubakirova; Svetlana Pak; Susan van den Hof
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.